200.2K XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Jeremy N Castle | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.16 per share. | 03 Dec 2024 | 1,130 | 81,330 | - | 0.2 | 181 | Common stock |
| Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 80,000 | 417,193 | - | 0 | Common stock | |
| Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 50,000 | 134,409 | - | 0 | Common stock | |
| Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 56,000 | 177,253 | - | 0 | Common stock | |
| Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 56,000 | 183,346 | - | 0 | Common stock | |
| Brad Hively | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 44,000 | 720,203 | - | 0 | Common stock | |
| Karen M. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 52,000 | 167,185 | - | 0 | Common stock | |
| Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 40,000 | 109,057 | - | 0 | Common stock | |
| Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 4,750 | 716,961 | - | 0.1 | 646 | Common stock |
| Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 4,977 | 711,984 | - | 0.1 | 677 | Common stock |
| Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 1,709 | 74,261 | - | 0.1 | 232 | Common stock |
| Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.13 per share. | 20 Nov 2024 | 267 | 73,994 | - | 0.1 | 36 | Common stock |
| Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 1,026 | 72,968 | - | 0.1 | 140 | Common stock |
| Robert Ross Carter | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.14 per share. | 20 Nov 2024 | 235 | 31,759 | - | 0.1 | 32 | Class A Common Stock |
| Mark L. Pacala | Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 30,372 | 84,409 | - | 0 | Common stock | |
| Mark L. Pacala | Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 20,248 | 114,781 | - | 0 | Common stock | |
| Daniel Virnich | Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 78,094 | 838,853 | - | 0 | Common stock | |
| Daniel Virnich | Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 117,142 | 721,711 | - | 0 | Common stock | |
| Yale Podnos | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 17,039 | 75,970 | - | 0 | Common stock | |
| Yale Podnos | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 11,359 | 93,009 | - | 0 | Common stock | |
| Brad Hively | Director | Purchase of securities on an exchange or from another person at price $ 0.17 per share. | 12 Nov 2024 | 250,000 | 616,753 | - | 0.2 | 42,500 | Common stock |
| Brad Hively | Director | Purchase of securities on an exchange or from another person at price $ 0.15 per share. | 12 Nov 2024 | 50,000 | 666,753 | - | 0.2 | 7,500 | Common stock |
| Brad Hively | Director | Other type of transaction at price $ 0.00 per share. | 12 Nov 2024 | 353,450 | 366,753 | - | 0 | Common stock | |
| Brad Hively | Director | Sale or transfer of securities back to the company at price $ 0.46 per share. | 17 Jun 2024 | 18,121 | 676,203 | - | 0.5 | 8,296 | Common Stock |
| Brad Hively | Director | Sale or transfer of securities back to the company at price $ 0.58 per share. | 22 May 2024 | 19,526 | 694,324 | - | 0.6 | 11,233 | Common Stock |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 151,459 | 474,931 | - | 0 | Common Stock | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 378,648 | 378,648 | - | - | Non-Qualified Stock Option (right to buy) | |
| Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 0.60 per share. | 21 May 2024 | 11,173 | 718,430 | - | 0.6 | 6,673 | Common Stock |
| Daniel Virnich | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 198,517 | 916,947 | - | 0 | Common Stock | |
| Daniel Virnich | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 496,293 | 496,293 | - | - | Non-Qualified Stock Option (right to buy) | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 17,530 | 104,368 | - | 0 | Common Stock | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 43,825 | 43,825 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jeremy N Castle | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 175,299 | 175,299 | - | - | Non-Qualified Stock Option (right to buy) | |
| Jeremy N Castle | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 70,120 | 82,460 | - | 0 | Common Stock | |
| Hively Brad | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 42,652 | 713,850 | - | 0 | Common stock | |
| Barasch Richard A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 80,000 | 337,193 | - | 0 | Common stock | |
| M. Anne McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 56,000 | 127,346 | - | 0 | Common stock | |
| M. Johnson Karen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 52,000 | 115,185 | - | 0 | Common stock | |
| Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 40,000 | 69,057 | - | 0 | Common stock | |
| Mark Pacala L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 46,630 | 135,029 | - | 0 | Common stock | |
| Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Dec 2023 | 53,326 | 121,253 | - | 0 | Common stock | |
| Shah Mihir | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 14 Dec 2023 | 99,435 | 327,557 | - | 1.3 | 126,282 | Common stock |
| Mihir Shah | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.25 per share. | 14 Dec 2023 | 565 | 328,122 | - | 1.2 | 706 | Common stock |
| Jeremy Castle N | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 12,340 | 12,340 | - | 0 | Common stock | |
| N Castle Jeremy | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Nov 2023 | 30,849 | 30,849 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brad Hively | Director | Sale or transfer of securities back to the company at price $ 2.19 per share. | 21 Nov 2023 | 25,867 | 671,198 | - | 2.2 | 56,726 | Common stock |
| Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 2.19 per share. | 21 Nov 2023 | 4,322 | 729,603 | - | 2.2 | 9,478 | Common stock |
| Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 2.19 per share. | 21 Nov 2023 | 1,530 | 86,838 | - | 2.2 | 3,355 | Common stock |
| Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. | 17 Nov 2023 | 25,000 | 722,065 | - | 0.9 | 21,250 | Common stock |
| Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2023 | 25,000 | 1,745,431 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brad Hively | Director | Sale of securities on an exchange or to another person at price $ 2.24 per share. | 17 Nov 2023 | 25,000 | 697,065 | - | 2.2 | 56,000 | Common stock |
| Daniel Virnich | Chief Executive Officer | Sale or transfer of securities back to the company at price $ 2.39 per share. | 14 Nov 2023 | 4,604 | 733,925 | - | 2.4 | 10,981 | Common stock |
| Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 2.38 per share. | 14 Nov 2023 | 1,860 | 88,368 | - | 2.4 | 4,436 | Common stock |
| Yale Podnos | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 2.39 per share. | 14 Nov 2023 | 238 | 90,228 | - | 2.4 | 568 | Common stock |
| Brad Hively | Director | Sale of securities on an exchange or to another person at price $ 2.52 per share. | 13 Nov 2023 | 47,000 | 724,182 | - | 2.5 | 118,581 | Common stock |
| Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2023 | 47,000 | 1,770,431 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brad Hively | Director | Sale or transfer of securities back to the company at price $ 2.39 per share. | 13 Nov 2023 | 27,117 | 697,065 | - | 2.4 | 64,755 | Common stock |
| Brad Hively | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.85 per share. | 13 Nov 2023 | 47,000 | 771,182 | - | 0.9 | 39,950 | Common stock |
| Mihir Shah | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.43 per share. | 23 May 2023 | 869 | 223,472 | - | 0.4 | 372 | Common Stock |
| Mihir Shah | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.43 per share. | 23 May 2023 | 2,573 | 224,341 | - | 0.4 | 1,101 | Common Stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 200 | 217,445 | - | 0.6 | 110 | Common stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 7,654 | 235,047 | - | 0.6 | 4,210 | Common stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 10,000 | 257,193 | - | 0.6 | 5,500 | Common stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 10,000 | 247,193 | - | 0.6 | 5,500 | Common stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 2,146 | 237,193 | - | 0.5 | 1,176 | Common stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 10,000 | 217,193 | - | 0.6 | 5,500 | Common stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 17 Mar 2023 | 52 | 217,245 | - | 0.6 | 29 | Common stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 0.55 per share. | 17 Mar 2023 | 9,948 | 227,393 | - | 0.5 | 5,471 | Common stock |
| Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 6,562 | 88,399 | - | 0 | Common stock | |
| Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 29,528 | 75,427 | - | 0 | Common stock | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 440,477 | 440,477 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 176,191 | 226,914 | - | 0 | Common stock | |
| Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 19,685 | 42,393 | - | 0 | Common stock | |
| Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 26,247 | 71,346 | - | 0 | Common stock | |
| Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 168,512 | 724,182 | - | 0 | Common stock | |
| Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 421,280 | 421,280 | - | - | Non-Qualified Stock Option (right to buy) | |
| Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 114,944 | 738,529 | - | 0 | Common stock | |
| Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 287,361 | 287,361 | - | - | Non-Qualified Stock Option (right to buy) | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 33,219 | 90,466 | - | 0 | Common stock | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 83,047 | 83,047 | - | - | Non-Qualified Stock Option (right to buy) | |
| Karen M. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 19,685 | 63,185 | - | 0 | Common stock | |
| Matthew Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 67,667 | 242,992 | - | 0 | Common stock | |
| Matthew Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 169,169 | 169,169 | - | - | Non-Qualified Stock Option (right to buy) | |
| Matthew Miller | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.95 per share. | 16 Dec 2022 | 73,684 | 175,325 | - | 1.0 | 70,000 | Common Stock |
| Daniel Virnich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 175,000 | 829,609 | - | - | Non-Qualified Stock Option (right to buy) | |
| Daniel Virnich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 07 Dec 2022 | 175,000 | 623,585 | - | 0.9 | 150,500 | Common Stock |
| Daniel Virnich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.86 per share. | 07 Dec 2022 | 175,000 | 448,585 | - | 0.9 | 150,500 | Common Stock |
| Daniel Virnich | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2022 | 175,000 | 654,609 | - | - | Non-Qualified Stock Option (right to buy) | |
| Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 164,727 | - | 0 | Common Stock | |
| Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 2,160 | 52,780 | - | 0 | Common Stock | |
| Mark L. Pacala | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 29,057 | 81,837 | - | 0 | Common Stock | |
| Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 45,899 | - | 0 | Common Stock | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 18,602 | 50,723 | - | 0 | Common Stock | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 94,418 | 94,418 | - | - | Non-Qualified Stock Option (right to buy) | |
| Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 48,242 | - | 0 | Common Stock | |
| Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 45,099 | - | 0 | Common Stock | |
| Brad Hively | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 525,188 | 525,188 | - | - | Non-Qualified Stock Option (right to buy) | |
| Brad Hively | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 103,469 | 555,670 | - | 0 | Common Stock | |
| Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 40,101 | 273,585 | - | 0 | Common Stock | |
| Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 203,543 | 203,543 | - | - | Non-Qualified Stock Option (right to buy) | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 14,164 | 57,247 | - | 0 | Common Stock | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 71,895 | 71,895 | - | - | Non-Qualified Stock Option (right to buy) | |
| Karen M. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 22,708 | 43,500 | - | 0 | Common Stock | |
| Matthew Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 119,825 | 119,825 | - | - | Non-Qualified Stock Option (right to buy) | |
| Matthew Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 23,607 | 101,641 | - | 0 | Common Stock | |
| Diona Simoneit | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 52,722 | 52,722 | - | - | Non-Qualified Stock Option (right to buy) | |
| Diona Simoneit | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 10,387 | 39,705 | - | 0 | Common Stock | |
| Gabriel Ling | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2022 | 29,057 | 29,057 | - | 0 | Common Stock | |
| Brad Hively | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 15 Nov 2022 | 9,718 | 452,201 | - | 2.0 | 19,706 | Common Stock |
| Daniel Virnich | President | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 15 Nov 2022 | 3,767 | 233,484 | - | 2.0 | 7,639 | Common Stock |
| Yale Podnos | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 15 Nov 2022 | 199 | 43,083 | - | 2.0 | 404 | Common Stock |
| Matthew Miller | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 15 Nov 2022 | 577 | 78,034 | - | 2.0 | 1,170 | Common Stock |
| Diona Simoneit | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 2.03 per share. | 15 Nov 2022 | 190 | 29,318 | - | 2.0 | 385 | Common Stock |
| Mohit Kaushal | Director | Sale of securities on an exchange or to another person at price $ 2.13 per share. | 14 Nov 2022 | 15,994 | 25,534 | - | 2.1 | 34,083 | Common Stock |
| Mohit Kaushal | Director | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 24 Oct 2022 | 4,798 | 41,528 | - | 5.0 | 23,798 | Common stock |
| Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 6,204 | 6,204 | - | - | Series A Common Stock Equivalent Convertible Preferred Stock | |
| Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 1 | 142,019 | - | 0 | Common stock | |
| Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 8 | 8 | - | 0 | Common stock | |
| Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 1,595 | 1,595 | - | - | Series A Common Stock Equivalent Convertible Preferred Stock | |
| Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 230 | 230 | - | - | Earnout rights (Series A Common Stock Equiv Conv Preferred) | |
| Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 894 | 894 | - | - | Earnout rights (Series A Common Stock Equiv Conv Preferred) | |
| Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 548,503 | 548,503 | - | - | Private Placement Warrants | |
| Richard A. Barasch | Director | Other type of transaction at price $ 0.00 per share. | 05 Oct 2022 | 73,024 | 73,024 | - | - | Earnout rights (Private placement warrants) | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 163,039 | 163,039 | - | - | Stock Options (right to buy) | |
| Mihir Shah | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 32,121 | 32,121 | - | 0 | Class A Common Stock | |
| Richard A. Barasch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 45,905 | 142,018 | - | 0 | Common stock | |
| Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 7,197 | 23,191 | - | 0 | Common stock | |
| Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 15,994 | 15,994 | - | 0 | Common stock | |
| Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 15,994 | 41,528 | - | 0 | Common stock | |
| Mohit Kaushal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 4,798 | 46,326 | - | 0 | Common stock | |
| Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 15,994 | 15,994 | - | 0 | Common stock | |
| Anne M. McGeorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 6,397 | 22,391 | - | 0 | Common stock | |
| Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 550,563 | 550,563 | - | - | Stock Option (right to buy) | |
| Daniel Virnich | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 213,259 | 213,259 | - | - | Stock Option (right to buy) | |
| Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 162,891 | 162,891 | - | - | Stock Option (right to buy) | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 10,984 | 10,984 | - | - | Stock Option (right to buy) | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 64,567 | 64,567 | - | - | Stock Option (right to buy) | |
| Karen M. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 4,798 | 20,792 | - | 0 | Common stock | |
| Karen M. Johnson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 15,994 | 15,994 | - | 0 | Common stock | |
| Matthew Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 109,844 | 109,844 | - | - | Stock Option (right to buy) | |
| Matthew Miller | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2022 | 32,417 | 32,417 | - | - | Stock Option (right to buy) | |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 7.20 per share. | 24 Nov 2021 | 1,200 | 96,113 | - | 7.2 | 8,643 | Common Stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 6.86 per share. | 24 Nov 2021 | 1,800 | 94,913 | - | 6.9 | 12,344 | Common Stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 6.81 per share. | 24 Nov 2021 | 2,000 | 93,113 | - | 6.8 | 13,618 | Common Stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 6.35 per share. | 23 Nov 2021 | 4,500 | 91,113 | - | 6.3 | 28,566 | Common Stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 6.27 per share. | 23 Nov 2021 | 500 | 86,613 | - | 6.3 | 3,133 | Common Stock |
| Richard A. Barasch | Director | Purchase of securities on an exchange or from another person at price $ 10.12 per share. | 16 Nov 2021 | 1,000 | 86,113 | - | 10.1 | 10,115 | Common Stock |
| Richard A. Barasch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 100,000 | 0 | - | - | Class B Common Stock | |
| Richard A. Barasch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 100,000 | 100,000 | - | - | Common Stock | |
| Richard A. Barasch | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Nov 2021 | 14,887 | 85,113 | - | - | Common Stock | |
| Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 4,109,771 | 4,109,771 | - | - | Common Stock | |
| Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 348,998 | 348,998 | - | - | Earn Out Rights | |
| Ravi Yang Sarin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 523,497 | 523,497 | - | - | Earn Out Rights | |
| Mohit Kaushal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 30,000 | 0 | - | - | Class B Common Stock | |
| Mohit Kaushal | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Nov 2021 | 30,000 | 30,000 | - | - | Common Stock | |
| Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 141,380 | 141,380 | - | 0 | Common Stock | |
| Brad Hively | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 212,070 | 363,450 | - | 0 | Common Stock | |
| Daniel Virnich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 78,094 | 78,094 | - | 0 | Common Stock | |
| Daniel Virnich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 578,006 | 68,208 | - | - | Stock Options (right to buy) | |
| Daniel Virnich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 426,603 | 426,603 | - | - | Stock Options (right to buy) | |
| Daniel Virnich | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 117,142 | 195,236 | - | 0 | Common Stock | |
| Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 71,350 | 118,916 | - | 0 | Common Stock | |
| Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 350,876 | 350,876 | - | - | Stock Options (right to buy) | |
| Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 261,023 | 261,023 | - | - | Stock Options (right to buy) | |
| Scott Dalgleish | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 47,566 | 47,566 | - | 0 | Common Stock | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 11,359 | 11,359 | - | 0 | Common Stock | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 77,916 | 77,916 | - | - | Stock Options (right to buy) | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 68,208 | 68,208 | - | - | Stock Options (right to buy) | |
| Yale Podnos | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 17,039 | 17,039 | - | 0 | Common Stock |